Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. hase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02381548 ...

    Clinical Trial last updated 05/03/2016 - 10:41am.

  2. Total Marrow Irradiation for Refractory Acute Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT00686556 ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  3. Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02044796 ...

    Clinical Trial last updated 04/28/2016 - 1:17pm.

  4. Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed/Refractory Acute Leukemia or High-Risk MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02543879 ...

    Clinical Trial last updated 04/28/2016 - 9:55am.

  5. Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01729845 ...

    Clinical Trial last updated 04/28/2016 - 9:51am.

  6. A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 Mutation (AML)

    ... Cohort 1 will enroll up to 26 patients with relapsed or refractory AML and confirmed FLT3 mutation without prior exposure to a FLT3 ... Cohort 2 will enroll up to 12 patients with relapsed or refractory AML and confirmed FLT3 mutation with prior exposure to a FLT3 ...

    Clinical Trial last updated 05/09/2016 - 4:09pm.

  7. A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.

    ... Patients with relapsed/ refractory leukemias or advanced myelodysplastic syndrome (MDS) fare poorly ...

    Research Article last updated 06/28/2013 - 1:30pm.

  8. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... Acute lymphocytic leukemia in relapse or primary refractory disease with a circulating blast count of no more than ... or C only) Acute myeloid leukemia in relapse or primary refractory disease with a circulating blast count of no more than 10,000/mm^3 ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  9. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... period to treat pediatric patients with relapsed or refractory hematologic malignancies or high risk solid tumors. ... curative transplant Relapsed or primary therapy- refractory AML with bone marrow blast < 20% High-risk ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  10. Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01757639 ...

    Clinical Trial last updated 04/21/2016 - 9:26am.